Transforming Alzheimer’s Investment with IXS Launchpad IXS Launchpad is reshaping healthcare investment by enabling global access to TauRx’s pioneering Alzheimer’s treatment. Through the launch of $TAU Digital, investors can now gain fractional ownership in TauRx Pharmaceuticals, a leading innovator in the fight against neurodegenerative diseases. This initiative demonstrates how tokenized real-world assets can direct meaningful capital into high impact medical research. By improving accessibility and reducing traditional barriers, IXS is helping accelerate the development of critical treatments and expanding participation in the future of medicine.